The company operates in two segments: Healthcare, which provides diagnostic and surgical services for injuries and disorders of the skeletal system and associated bones, joints, tendons, muscles, ligaments, and nerves, and Real Estate. Primary operations are conducted through subsidiaries Nova Ortho and Spine, LLC, a healthcare services provider, and Edge View Properties, Inc., a real estate company.
Cyborg Score Rationale
In 2025, Cardiff Lexington's revenue was $11.54 million, an increase of 39.48% compared to the previous year's $8.27 million. However, losses were -$6.54 million, 53.4% more than in 2024, and management identified material weaknesses in internal controls over financial reporting.
Top Insights
FY2025 revenue growth accelerated 39.48% to $11.54 million (March 2026 disclosure)
Sold financial services subsidiary Platinum Tax Defenders in 2023, refocusing on healthcare operations
Material weaknesses in internal controls identified; company taking steps to hire personnel and enhance processes
Operates primarily in niche orthopedic and spine care sectors targeting personal injury attorneys and insurance carriers
Named Competitors
Encompass Health — Specialized orthopedic and spine rehabilitation services
Surgery Partners — Orthopedic and surgical services platform
Regional Healthcare Providers — Local orthopedic and spine practice networks
Recent Developments
(May 2026) Filed financial results showing 39.5% FY25 revenue increase to $11.5 million
(April 2026) Announced FY25 results with 62.7% gross profit increase to $7.2 million
(March 2026) Hosted investor conference call on financial and operational updates
Open the full interactive Cardiff Lexington Corporation report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.